뒤로
UCB SA(UCBJY) 가격
UCBJY 주가 차트
UCBJY 배당금
UCB SA
$151.15
-3.91%
$-6.16
종가: Jan 28, 16:00:00 GMT-5
$151.15
0%
$0
프리마켓: Jan 29, 07:34:25 GMT-5
주요 통계
이전 종가
$157.32
시가
$150.82
일일 범위
$150.07 - $151.22
52주 범위
$71.15 - $154.91
거래량
2.7K
평균 거래량
26.2K
EPS(TTM)
4.03
배당수익률
--
시가총액
$57.4B
UCB S.A.란 무엇인가요?
UCB SA engages in the research and development of biopharmaceuticals products. The company is headquartered in Anderlecht, Bruxelles-Capitale and currently employs 9,378 full-time employees. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and respiratory disease. In addition to its core fields of business, Ucb SA delivers molecule solutions to specialists for use in the treatment of severe diseases. Its product portfolio includes drugs, such as Neupro, Vimpat, Cimzia, among others. Ucb SA also operates in primary care to support specialist products that are administered by primary care physicians.